Members of the Weill Cornell Medical College Class of 2024 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
The FDA announced the nasal spray based form of Narcan – which reverses opioid overdoses and previously required a prescription – can now be sold over the counter.
Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.
Cathy Garzio, a distinguished academic medicine administrator, has been appointed executive vice provost and chief operating officer of Weill Cornell Medicine, effective early February.
Structural insights into a potent antimalarial drug candidate’s interaction with a malaria parasite have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.
Cornell researchers have harnessed the power of baker’s yeast to create a cost-effective and highly efficient approach for unraveling how plants synthesize medicinal compounds, and they have used the new method to identify key enzymes in a kratom tree.
Fungal biologist Lori Huberman will use a $1.9 million grant from the National Institutes of Health to study how fungi sense and use nutrients, basic research with potential applications for treatment of cancer, obesity, Type 2 diabetes and fungal infections.
The lack of alcohol in nonalcoholic or low-alcohol beer – particularly during manufacturing, storage and pouring – may prompt conditions ripe for foodborne pathogen growth.
